Okamoto, M. et al. Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: a longitudinal cohort study. PLoS ONE 13, e0195147 (2018).
Ou, H., Fu, Y., Liao, W., Zheng, C. & Wu, X. Association between smoking and liver fibrosis among patients with nonalcoholic fatty liver disease. Can. J. Gastroenterol. Hepatol. 2019, 6028952 (2019).
Jung, H. S. et al. Smoking and the risk of non-alcoholic fatty liver disease: a cohort study. Am. J. Gastroenterol. 114, 453–463 (2019).
Takenaka, H. et al. Non-alcoholic fatty liver disease is strongly associated with smoking status and is improved by smoking cessation in Japanese males: a retrospective study. Kobe J. Med. Sci. 66, E102–E112 (2020).
Yuan, S. et al. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study. Eur. J. Epidemiol. 37, 723–733 (2022).
WHO Report on the Global Tobacco Epidemic 2008: The MPOWER Package 14 (WHO, 2008).
WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000–2025, Second Edition 21 (WHO, 2018).
Holford, T. R. et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA 311, 164–171 (2014).
Xue, S., Schlosburg, J. E. & Janda, K. D. A new strategy for smoking cessation: characterization of a bacterial enzyme for the degradation of nicotine. JACS 137, 10136–10139 (2015).
Dulchavsky, M., Clark, C. T., Bardwell, J. C. A. & Stull, F. A cytochrome c is the natural electron acceptor for nicotine oxidoreductase. Nat. Chem. Biol. 17, 344–350 (2021).
Tripathi, A. et al. The gut-liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397–411 (2018).
Lindell, G. et al. Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand. J. Gastroenterol. 28, 487–494 (1993).
Han, X. J. et al. Stimulation of α7 nicotinic acetylcholine receptor by nicotine suppresses decidual M1 macrophage polarization against inflammation in lipopolysaccharide-induced preeclampsia-like mouse model. Front. Immunol. 12, 642071 (2021).
Sousa, M. V. et al. Smoking accelerates renal cystic disease and worsens cardiac phenotype in Pkd1-deficient mice. Sci. Rep. 11, 14443 (2021).
Wu, X. X. et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 9, 171 (2018).
Fluhr, L. et al. Gut microbiota modulates weight gain in mice after discontinued smoke exposure. Nature 600, 713–719 (2021).
Wang, S. N., Liu, Z., Tang, H. Z., Meng, J. & Xu, P. Characterization of environmentally friendly nicotine degradation by Pseudomonas putida biotype A strain S16. Microbiology 153, 1556–1565 (2007).
Tang, H. Z. et al. A novel gene, encoding 6-hydroxy-3-suceinoylpyridine hydroxylase, involved in nicotine degradation by Pseudomonas putida strain S16. Appl. Environ. Microbiol. 74, 1567–1574 (2008).
Wang, C. et al. Nicotine accelerates atherosclerosis in apolipoprotein E-deficient mice by activating α7 nicotinic acetylcholine receptor on mast cells. Arterioscler. Thromb. Vasc. Biol. 37, 53–65 (2017).
Liu, R., Kurose, T. & Matsukura, S. Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats. Metabolism 50, 79–85 (2001).
Wu, Y. et al. Activation of AMPKα2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat. Med. 21, 373–382 (2015).
Garcia, D. & Shaw, R. J. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell 66, 789–800 (2017).
Marra, F. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J. Hepatol. 68, 280–295 (2018).
Xue, Y. et al. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics 7, 1598–1608 (2008).
Filosto, S., Ashfaq, M., Chung, S., Fry, W. & Goldkorn, T. Neutral sphingomyelinase 2 activity and protein stability are modulated by phosphorylation of five conserved serines. J. Biol. Chem. 287, 514–522 (2012).
Wu, Q. et al. Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis. J. Clin. Invest. 131, e142865 (2021).
Lindell, G., Lunell, E. & Graffner, H. Transdermally administered nicotine accumulates in gastric juice. Eur. J. Clin. Pharmacol. 51, 315–318 (1996).
Mu, Y. et al. Bacterial catabolism of nicotine: catabolic strains, pathways and modules. Environ. Res. 183, 109258 (2020).
Gunasekaran, M. Direct evidence that sunbirds’ gut microbiota degrades floral nectar’s toxic alkaloids. Front. Microbiol. 12, 639808 (2021).
Agostoni, C. et al. Scientific opinion on the safety of ‘heat-treated milk products fermented with Bacteroides xylanisolvens DSM 23964’ as a novel food EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). EFSA J. 13, 3956 (2015).
Lavrynenko, O. et al. Ceramide ratios are affected by cigarette smoke but not heat-not-burn or e-vapor aerosols across four independent mouse studies. Life Sci. 263, 118753 (2020).
Tippetts, T. S. et al. Cigarette smoke increases cardiomyocyte ceramide accumulation and inhibits mitochondrial respiration. BMC Cardiovasc. Disord. 14, 165 (2014).
Zhou, Y. J. et al. Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 54, 470–480 (2021).
Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313–1321 (2005).
Lloyd-Jones, D. M. et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am. J. Cardiol. 94, 20–24 (2004).
Hippisley-Cox, J., Coupland, C. & Brindle, P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357, j2099 (2017).
Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013).
Wu, Q. et al. Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis. Cell Metab. 33, 1988–2003 (2021).
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
Dhariwal, A. et al. MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res. 45, W180–W188 (2017).
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
Liu, C. et al. Enlightening the taxonomy darkness of human gut microbiomes with a cultured biobank. Microbiome 9, 119 (2021).
Despres, J. et al. Unraveling the pectinolytic function of Bacteroides xylanisolvens using a RNA-seq approach and mutagenesis. BMC Genom. 17, 147 (2016).
Apsunde, T. D. & Trudell, M. L. Microwave-assisted iridium-catalyzed synthesis of nicotine and anabasine derivatives. Synthesis 45, 2120–2124 (2013).
Dye, F. S. et al. Characterisation of proguanylin expressing cells in the intestine evidence for constitutive luminal secretion. Sci. Rep. 9, 15574 (2019).
Xuan, Q. H. et al. Development of a high coverage pseudotargeted lipidomics method based on ultra-high performance liquid chromatography-mass spectrometry. Anal. Chem. 90, 7608–7616 (2018).
Ren, L. L. et al. TiO2 with tandem fractionation (TAFT): an approach for rapid, deep, reproducible, and high-throughput phosphoproteome analysis. J. Proteome Res. 17, 710–721 (2018).
Liu, P. et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508, 541–545 (2014).
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018).
More News
Author Correction: Bitter taste receptor activation by cholesterol and an intracellular tastant – Nature
Audio long read: How does ChatGPT ‘think’? Psychology and neuroscience crack open AI large language models
Ozempic keeps wowing: trial data show benefits for kidney disease